| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.4M | -4.1% |
| Cost of Revenue | $403K | -9.4% |
| Gross Profit | $977K | -1.7% |
| R&D Expense | $53K | -65.0% |
| SG&A Expense | $3.6M | +119.2% |
| Pre-tax Income | -$3.1M | -233.8% |
| Income Tax | $5K | — |
| Net Income | -$3.1M | -234.4% |
| EPS (Basic) | -$0.29 |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $160K | -13.9% |
| Current Assets | $4.8M | +567.9% |
| Total Assets | $5.0M | +600.0% |
| Current Liabilities | $519K | -14.0% |
| Total Liabilities | $519K | -14.0% |
| Stockholders' Equity | $4.5M | +3791.4% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.6M | -418.4% |
| Capital Expenditures | $2K | — |
| Investing Cash Flow | -$251K | — |
| Financing Cash Flow | $7.7M | +568.9% |
| Free Cash Flow | -$3.6M | — |
| -190.0% |
| EPS (Diluted) | -$0.29 | -190.0% |